Dendritic cell (DC)-based vaccines have been used to generate Th1-mediated,
protective immunity against cancers and infectious microorganisms. As an a
ttempt to develop a new vaccine protocol for the induction of Th2-directed
responses, we introduced an IL-4 plasmid vector into the XS106 DC line (der
ived from A/J mice). Although relatively small fractions of XS106 cells exh
ibited apparent intracellular deposition of IL-4, they secreted biologicall
y relevant amounts of the cytokine. IL-4-transduced XS106 DC and control XS
106 DC transfected with vector alone were pulsed with KLH and injected s.c.
into A/J mice. The overall magnitude of KLH-specific cellular and humoral
responses was comparable between the two animal groups. However, they diffe
red in the isotype profile albeit only transiently, with the IL-4-transduce
d DC group showing higher IgE and lower IgG2a responses, and in the cytokin
e profile, with spleen cells isolated from the IL-4-transduced DC group pro
ducing higher IL-13 and lower IL-12. Thus, delivery of IL-4 gene to relativ
ely small numbers of DC is sufficient to modify the immunological outcome o
f DC-based vaccines. (C) 2000 Elsevier Science Ltd. All rights reserved.